CFO Ollet John bought 10,000 shares of HCWC at $10.00 for $100.0K; cluster pattern with 2 other insider buys in 14 days
Ollet John, Chief Financial Officer, purchased 10,000 shares at $10.00 on 2024-09-17, increasing his holdings by 10.6% to 104,544 shares total. This represents a $100,000 commitment by the company's financial officer just 3 trading days after HCWC's recent listing. The transaction is part of a broader pattern: 2 other insiders have also bought within the past 14 days, establishing a cluster buy dynamic. This synchronized purchasing activity across multiple company principals warrants close attention, particularly given the recent IPO timing and the CFO's material cash deployment at the post-listing price point.
CEO Holman Jeffrey Elliot bought 10,000 shares at $10.00 on 2024-09-17; part of cluster buy pattern with 2 other insiders in past 14 days
CEO Holman Jeffrey Elliot purchased 10,000 shares at $10.00, increasing his holdings to 279,852 shares, representing a +3.7% increase. This transaction is part of a cluster buy pattern in which 2 other insiders also purchased shares within the past 14 days. The stock is trading at $3.50 as of 2024-09-18, only 3 trading days after listing. The concurrent buying activity by multiple insiders near the IPO window, combined with the CEO's personal investment, warrants investor attention to understand the underlying business case and the context driving simultaneous insider acquisitions during the early trading phase.
HCWC President Santi Christopher buys 5,000 shares at $10.00; cluster pattern with 2 other insiders buying within 14 days
Santi Christopher, President of Healthy Choice Wellness Corp., purchased 5,000 shares at $10.00 on 2024-09-17, just 3 trading days after the company's recent listing, increasing his holdings from 144.9K to 149.9K shares. This transaction is part of a cluster buy pattern involving 2 other insiders who also purchased shares within the past 14 days, suggesting coordinated activity among the leadership team around the recent IPO. The stock currently trades at $3.50, reflecting significant post-IPO price deterioration from the transaction price of $10.00. The timing and structure—multiple insiders buying near the listing date despite subsequent price decline—warrants scrutiny into IPO pricing dynamics and insider motivation in a newly listed company.
Add HCWC to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.
